Giulia Matacchione
Overview
Explore the profile of Giulia Matacchione including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
917
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diotallevi F, Esposito M, Fargnoli M, Quaglino P, Mastorino L, Stingeni L, et al.
Dermatol Ther (Heidelb)
. 2025 Jan;
15(2):323-336.
PMID: 39847259
Introduction: Palmoplantar psoriasis (PPp) has a profound negative impact on patients' quality of life, and it represents a therapeutic challenge, as palms and soles are difficult to treat area. Although...
2.
Diotallevi F, Matacchione G, Campanati A, Marinelli Busilacchi E, Viola N, Pace I, et al.
Dermatol Ther (Heidelb)
. 2025 Jan;
15(1):125-140.
PMID: 39800831
Introduction: Psoriasis is characterized by aberrant keratinocyte activity and immune cell infiltration, driven by immune-mediated pathways. MicroRNAs (miRNAs) play crucial roles in regulating these processes, offering insights into disease mechanisms...
3.
Venturini C, Mancinelli L, Matacchione G, Olivieri F, Antonicelli R
Nutrients
. 2024 Dec;
16(23).
PMID: 39683597
Cardiovascular diseases (CVDs) persist as the primary cause of death worldwide, accounting for roughly 17.9 million fatalities each year. The prevalence of obesity, metabolic syndrome, and type 2 diabetes (key...
4.
Matacchione G, Piacenza F, Pimpini L, Rosati Y, Marcozzi S
Clin Epigenetics
. 2024 Nov;
16(1):175.
PMID: 39614396
Background: The gut microbiota (GM) plays a critical role in regulating human physiology, with dysbiosis linked to various diseases, including heart failure (HF). HF is a complex syndrome with a...
5.
Ghosh P, Fontanella R, Scisciola L, Taktaz F, Pesapane A, Basilicata M, et al.
Ageing Res Rev
. 2024 Oct;
101:102533.
PMID: 39368666
Obesity is one of the most prevalent and increasing metabolic disorders and is considered one of the twelve risk factors for dementia. Numerous studies have demonstrated that obesity induces pathophysiological...
6.
Cecchini S, Di Rosa M, Fantechi L, Mecozzi S, Matacchione G, Giuliani A, et al.
Geriatr Gerontol Int
. 2024 Jul;
24(9):962-972.
PMID: 39037206
Aim: Chest computed tomography (CT) scan is useful to evaluate the type and extent of lung lesions in coronavirus disease 2019 (COVID-19) pneumonia. This study explored the association between radiological...
7.
DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Sabbatinelli J, Giuliani A, Kwiatkowska K, Matacchione G, Belloni A, Ramini D, et al.
Cardiovasc Diabetol
. 2024 Jul;
23(1):250.
PMID: 39003492
Background: Individuals with type 2 diabetes (T2D) face an increased mortality risk, not fully captured by canonical risk factors. Biological age estimation through DNA methylation (DNAm), i.e. the epigenetic clocks,...
8.
Barbieri M, Prattichizzo F, La Grotta R, Matacchione G, Scisciola L, Fontanella R, et al.
Ageing Res Rev
. 2024 Jul;
99:102405.
PMID: 38971321
Diabetes mellitus, a metabolic condition affecting around 537 million individuals worldwide, poses significant challenges, particularly among the elderly population. The etiopathogenesis of type 2 diabetes (T2D) depends on a combination...
9.
Pimpini L, Biscetti L, Matacchione G, Giammarchi C, Barbieri M, Antonicelli R
J Clin Med
. 2024 Jun;
13(12).
PMID: 38930095
Atrial fibrillation (AF) has been associated with higher morbidity and mortality rates, especially in older patients. Subclinical atrial fibrillation (SCAF) is defined as the presence of atrial high-rate episodes (AHREs)...
10.
Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, et al.
N Engl J Med
. 2024 Mar;
390(10):900-910.
PMID: 38446676
Background: Microplastics and nanoplastics (MNPs) are emerging as a potential risk factor for cardiovascular disease in preclinical studies. Direct evidence that this risk extends to humans is lacking. Methods: We...